
Thought leadership ads on LinkedIn work in medtech when you put paid reach behind a post an early adopter surgeon wrote about your product. The post earns trust, and the ad puts it in front of the surgeons you want.
You have one surgeon who loves the device and wants to tell people. Left alone, that surgeon will write a vague post that nobody stops to read.
Key Takeaways

Thought leadership ads on LinkedIn promote a real person's post, so a surgeon's account of adopting your device reaches a wider group of surgeons. The post carries the credibility and the ad carries the reach.
I covered this on an episode about using LinkedIn ads to attract early adopter surgeons and discover KOLs. The idea starts with early adoption. You take an organic LinkedIn post from an innovator and put ads behind it.
When we recorded in September 2024, we noted that LinkedIn lets you narrow an audience by role, title, company size and location, with exclusions. That precision is why paid reach works so well for a niche like surgeons.
It also means you have to be structured. A LinkedIn campaign without a plan burns budget quickly.
For the bigger picture of who these adopters are and why they matter, see how the technology adoption curve shaped Intuitive Surgical's market.

Write the post for the surgeon, because a generic post won't stop the scroll. Give it a hook that names the reader and a promise that makes them click "see more," then ask the surgeon to publish it in their own voice.
Here's the rule I gave on the episode.
"It's very important you do not allow your adopter or whoever's going to post to just write whatever they want and post it."
Most surgeons wouldn't know how to copywrite a post like this. The post has to be engineered so that someone who sees it is likely to engage.
"You want to write a scroll stopping hook, a curiosity generating promise."
For a bariatric surgeon, I'd put the identifier in the first line, such as "As a bariatric surgeon, I've been looking for a technology that can improve my practice." Then I'd add a pointing-down arrow to get the click.
That identifier in the first line stops the right reader.
The image matters just as much. Make the surgeon the focal point instead of the technology, so the user is the hero.
Then brighten it in Canva or any editor to stop the scroll, and use three to nine hashtags, a mix of broad ones like medtech and narrow ones like robotic surgery.
I'd also tell the rep in the room to take the photo and draft the copy. Then the surgeon only has to approve and post.

Run the ad about 72 hours after the surgeon posts, on a brand awareness objective, aimed at the post itself. Target your ideal customer profile by job title and by groups, and let it run for around two weeks.
Give the organic post time first.
"Once they post this kind of a post organically on their LinkedIn, give it about 72 hours, that's what the LinkedIn algorithm is going to do its thing with it."
Next, choose how to promote it. LinkedIn has an ad feature where you select a person's post to promote. On the episode I said it sometimes didn't work for me, because the person had to have tagged your company and the post didn't always appear.
My simpler method was to take a screenshot of the post and run it as an image ad. It looks like a normal post in the feed, and when someone clicks it, they land on the organic post.
"You do not want to drive them to a website. This is not for a conversion event."
Pick the brand awareness objective and put the ad in front of as many people who fit your ideal customer profile as you can. Think beyond titles.
If you target bariatric and general surgeons, search LinkedIn for the groups they join and add those to your targeting.
Let it run for two weeks, and a month is fine. The episode also included a warning I'd repeat. Run thought leadership ads as a separate bucket, because LinkedIn will optimize for likes and clicks.
Mixed in with other campaigns, it will skew your metrics and eat your budget.
Treat likes as a signal, then reach out to the surgeons who liked the post. A like is a low-friction action, so it shows you who is interested before anyone fills in a form.
I explained why on the episode.
"Very easy for somebody to commit to a like."
Clicking a link, filling in a form and booking a demo asks for a lot. Strong intent takes a lot of money and marketing. A like asks for almost nothing, so you can see interest earlier.
Check who liked the post. Then reach out, whether it's you or your sales team, and say you noticed they liked the surgeon's post. Offer more information, or send a recording of your demo.
You can also use likes to check your assumptions. If the surgeon is an adviser to your company, ask for an introduction to the physicians engaging with the content. Then you don't have to guess who is persuasive.
I like this because it's cheap. It also keeps your outreach grounded in real behavior.
For the editorial side of this, read my guide to how healthcare content marketing builds a pipeline.
It means your best surgeon is a media channel, and paid reach makes the channel larger. Do the work on the post first, then spend, because paid reach on a weak post only shows it to more surgeons.
In my experience working with medtech founders, the early adopter is usually an underused asset. Clinical validation isn't commercial traction, and FDA clearance is the starting line, not the finish line.
A surgeon who tells peers why they adopted your device builds the trust a launch needs.
This is a market engineering move. At MarketCraft, we build the market narrative first, so every adopter post, ad and outreach message points the same way. Great companies don't wait for markets to form. They engineer them.
To test this over a quarter, start with one early adopter who already shares content. Draft the post with a hook and a promise, and take the photo.
Wait 72 hours, then boost the post for two weeks. After that, reach out to the surgeons who liked it, because they've already told you the topic matters to them.
To pick the right adopters, see how to find key opinion leaders through several micro-influencers. On The State of MedTech, I keep returning to this because trust travels through peers.
They're ads that promote a specific person's LinkedIn post, such as a surgeon describing why they adopted your device. The post is the content and the ad is the reach.
In 2024 I found the feature unreliable. I also ran the same idea with a screenshot of the post as an image ad.
Give the organic post about 72 hours first. That's the time the LinkedIn algorithm needs to show how the post performs on its own.
Then run the ad for about two weeks. A month also works, as long as the post is still relevant.
Use brand awareness and send people to the post. The ad isn't a conversion event, so a form fill is the wrong measure.
We also suggested testing an engagement objective, since you want likes and comments on the post.
Look at which surgeons liked the post. Then reach out to them directly, either yourself or through your sales team.
Say you noticed they liked the post, and offer more information or a recording of a demo. Likes show interest earlier than a form fill does.
If you're doing this yourself. Start with one adopter and the sequence above, and use the medtech commercialization strategy guide to see where it fits. Listen to The State of MedTech for more on early adopters.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. We'd look at which adopters and which narrative will earn trust fastest.
My full episode on using LinkedIn ads to attract early adopter surgeons is available on The State of MedTech. Watch on YouTube. Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth.
Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.